BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
- Status
- COMPLETED
- Phase
- PHASE3
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Healthy Exercise for Lymphoma Patients (HELP)
- Status
- UNKNOWN
- Phase
- PHASE3
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
Campath-1H + FK506 and Methylprednisolone for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
- Status
- COMPLETED
- Phase
- PHASE3
S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia
- Status
- TERMINATED
- Phase
- PHASE1